Atticus Wealth Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Atticus Wealth Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-50	Closed	-$11K	–	403
2021 Q1	$11K	Hold	50	–	–	0.01%	297
2020 Q4	$6K	Hold	50	–	–	﹤0.01%	303
2020 Q3	$5K	Hold	50	–	–	﹤0.01%	278
2020 Q2	$6K	Hold	50	–	–	﹤0.01%	265
2020 Q1	$4K	Buy	+50	New	+$5.29K	﹤0.01%	261

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Atticus Wealth Management's GWPH Position: Q2 2021 in Review

Atticus Wealth Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 50 shares — an estimated $11K sold.

Atticus Wealth Management first reported a position in GWPH in Q1 2020 and held it in 5 quarters. The position peaked at $11K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Atticus Wealth Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Atticus Wealth Management sold 50 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $11K.
Atticus Wealth Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2020 and held it in 5 quarters.
Atticus Wealth Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $11K in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Atticus Wealth Management's 13F filing for Q2 2021, filed 21 Jul 2021.